期刊文献+

2型糖尿病合并骨质疏松骨量及血清瘦素、骨代谢指标对照分析 被引量:5

原文传递
导出
摘要 目的分析2型糖尿病(2DM)合并骨质疏松(OP)患者骨量及血清瘦素、骨代谢指标。方法连续选择近期就诊的37例2DM合并OP患者、41例单纯OP患者和28例同龄、同性别及正常骨密度(BMD)的健康体检者(对照组),三组对象接受了腰椎L1~L4BMD、左侧股骨颈BMD、血清瘦素(LEP)、骨钙素(BGP)和碱性磷酸酶(AKP)等指标测定。结果 2DM合并OP组的腰椎L1~L4及股骨颈BMD、外周血LEP浓度明显低于单纯OP患者和对照组,而血清BGP和AKP浓度则明显高于后两者(P均<0.01~0.05)。结论 2DM合并OP患者存在着较明确骨量减少及血清LEP低水平表达,但骨转换指标活跃。
出处 《中国误诊学杂志》 CAS 2012年第4期786-786,共1页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

二级参考文献43

  • 1肖新怀,陈澍,苏丽芳.老年2型糖尿病患者瘦素与骨量关系的研究[J].实用医学杂志,2005,21(1):41-42. 被引量:5
  • 2Saller A,Maggi S, Romanato G, et al. Diabetes and osteoporosis. Aging Clin Exp Res, 2008,20:280-289.
  • 3Xu L,Cheng M, Liu XQ, et al. Bone mineral density and its related factors in elderly male Chinese patients with type- 2 Diabetes. Arch Med Res, 2007, 38 259-264.
  • 4He H, Liu R, Desta T, et al. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology, 2004,145:447-452.
  • 5Okazaki R,Totsuka Y, Hamano K, et al. Metabolic improvement of poorly controlled noninsulin- dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab, 1997,82:2915-2920.
  • 6Thomas T,Gori F, Khosla S, et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology, 1999, 140,1630-1638.
  • 7Holloway WR,Collier FM, Aitken CJ, et al. Leptin inhibits osteoclast generation. J Bone Miner Res , 2000, 17:200-209.
  • 8Ducy P, Amling M,Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell, 2000, 100: 197-207.
  • 9Jiang LS, Zhang ZM, Jiang SD, et al. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis. J Bone Miner Res, 2008,23:475-483.
  • 10Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue [ J]. Nature, 1994,372 ( 6505 ) :425-432.

共引文献24

同被引文献67

  • 1朱翔,章秋.糖尿病性骨质疏松及其影响因素[J].实用糖尿病杂志,2006,2(4):6-8. 被引量:33
  • 2尤婷婷,吴铁,张志平,邹丽宜,黄礴.高脂血症致大鼠骨质疏松作用研究初探[J].中国临床药理学与治疗学,2007,12(3):299-303. 被引量:32
  • 3国家中医药管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:29.
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 5中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J/CD].中国医学前沿杂志:电子版,2011,3(6):54-109.
  • 6Bird SB,Dickson EW.Clinically significant changes in pain along the visual analog scale[J].Ann Emerg Med,2001,38(6):639-643.
  • 7Rkel A,Sheehy O,Rahme E,et al.Osteoporosis among patients with type 1 and type 2 diabetes[J].Diabetes Metab,2008,34(3):193-205.
  • 8Wada S,Kamiya S,Fukawa T.Bone quality changes in diabetes[J].Clin Calcium,2008,18(5):600-605.
  • 9Kwon DJ,Kim JH,Chung KW,et al.Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with noninsulin-dependent diabetes mellitus[J].J Obstet Gynaecol Res,1996,22(2):157-162.
  • 10Leidig-Bruckner G,Ziegler R.Diabetes Mellitus a risk for osteoporosis?[J].Exp Clin Endocrinol Diabetes,2001,109(Suppl 2):S493-514.

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部